SREBF1 and neoplasm: reported that p53, an important tumor suppressor, can repress SREBP1 expression via the p21 (cyclin-dependent kinase inhibitor 1A)/Rb/E2F transcription factor pathway, resulting in SCD and a subsequent decrease in mono-unsaturation of phospholipid acyl chains (27).